Ohr Pharmaceuticals Cash Flow - Annual (NASDAQ:OHRP)

Add to My Stocks
$0.18 $0 (0%) OHRP stock closing price Sep 20, 2018 (Closing)

For analyzing any company like Ohr Pharmaceuticals from an investment perspective, its important to check the cash flow statement. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Ohr Pharmaceuticals profits one has to check the income statement and for Ohr Pharmaceuticals debt one has to check the balance sheet. Ohr Pharmaceuticals cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. Ohr Pharmaceuticals had cash and cash equivalents of $12.54M at the beginning of the year and $12.8M at year end for 2017. Ohr Pharmaceuticals saw a outflow of $- from investing activities for 2017.

View details of Ohr Pharmaceuticals cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Oct - Sep2017201620152014201320122011201020092008
Net Income Cash Flow
-23.81M-25.76M-15.19M-9.13M-5.65M-1.45M-5.1M--0.86M-
Depreciation Depletion Amortization Cash-Flow1.16M1.18M1.51M-------
Net Increase (Decrease) in Assets Liabilities1.31M4.63M-1.29M----0.02M---0.13M
Cash From (used in) Discontinued Operations----------0.68M
Other Adjustments Net2.04M3.95M4.28M3.26M2.46M-0.48M4.03M-1.14M--
Net Cash from (used by) Operating Activities
-19.29M-15.98M-10.69M-5.36M-2.68M-1.75M-1M-0.52M-0.41M-0.51M
Increase (Decrease) in Prop Plant And Equipment--0.01M-0.18M---0.03M--0.02M--
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments---0.1M-0.02M------
Other Cash Inflow (Outflow) from Investment Activities----3.5M-----0.3M-
Net Cash from (used by) Investment Activities
--0.01M-0.28M-3.51M--0.03M--0.02M-0.3M-
Issuance (Purchase) of Equity Shares19.69M-26.66M17.13M5.25M4M1.05M1M1M-
Issuance (Repayment) of Debt Securities-------0.05M-0.39M-0.04M-
Increase (Decrease) in Bank & Other Borrowings-0.24M-0.17M-0.2M-0.16M-0.07M-0.05M-0.01M---
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
19.45M-0.15M26.45M16.97M5.18M3.94M----
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
--16.15M15.47M8.09M2.49M2.16M----0.1M
Cash & Equivalents at Beginning of Year12.54M28.69M13.22M5.12M2.63M-----
Cash & Equivalents at Year End12.8M12.54M28.69M13.22M5.12M2.63M----
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Pfizer financial analysis

Ohr Pharmaceuticals stock comparison chart provides an easy way to compare the stock price with peers along with details of Ohr Pharmaceuticals stock price history.
The statement of cash flows can be categorized into three main sections:

  • Ohr Pharmaceuticals has cash of $12.8M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Ohr Pharmaceuticals stock price.
  • Cash Flow from operating activities: Ohr Pharmaceuticals reported a negative operating cash flow of $-19.29M for 2017 and has seen a decrease from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash from investing stood at a negative value of $- for OHRP stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $19.45M for Ohr Pharmaceuticals.

Key Financial Ratios For Ohr Pharmaceuticals Cash Flow